Corporate Board Profile
Tech Score: 11/100
1 mention(s) identify CHRISTOPHER ANZALONE as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | 2009-01-28 | Dr. Anzalone was founding CEO in two portfolio companies, Nanotope Inc., a tissue regeneration company, and Leonardo Biosystems Inc., a cancer drug delivery company. Prior to his tenure at Benet Group, from 1999 until 2003, he was a partner at the Washington, DC-based private equity firm Galway Partners, LLC. There, he was in charge of sourcing, structuring, and building new business ventures and was founding CEO of NanoInk, Inc., a leading nanolithography company. He continued as CEO of NanoInk until 2004. Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. | He was founding CEO of NanoInk, Inc., a leading nanolithography company, and has a Ph.D. in Biology. His roles involved technical leadership in nanobiotechnology companies, indicating technical expertise likely including programming or related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2009-01-28 | Dr. Anzalone was founding CEO in two portfolio companies, Nanotope Inc., a tissue regeneration company, and Leonardo Biosystems Inc., a cancer drug delivery company. Prior to his tenure at Benet Group, from 1999 until 2003, he was a partner at the Washington, DC-based private equity firm Galway Partners, LLC. There, he was in charge of sourcing, structuring, and building new business ventures and was founding CEO of NanoInk, Inc., a leading nanolithography company. He continued as CEO of NanoInk until 2004. Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. |
| 2010-04-30 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. He was founding CEO of NanoInk, Inc., a leading nanolithography company. |
| 2011-06-27 | Dr. Anzalone holds a Ph.D. in Biology and has extensive experience in nanotechnology, biotechnology, company-building and venture capital, but no mention of software or programming skills. |
| 2012-01-12 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. We believe Dr. Anzalone’s qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer; in addition Dr. Anzalone has extensive experience in nanotechnology, biotechnology, company-building and venture capital. |
| 2013-02-04 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. We believe Dr. Anzalone’s qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer; in addition Dr. Anzalone has extensive experience in nanotechnology, biotechnology, company-building and venture capital. |
| 2013-12-20 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. We believe Dr. Anzalone’s qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer; in addition Dr. Anzalone has extensive experience in biotechnology, nanotechnology, company-building and venture capital. |
| 2015-01-23 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University... extensive experience in biotechnology, nanotechnology, company-building and venture capital. |
| 2016-01-19 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. We believe Dr. Anzalone’s qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer; in addition, Dr. Anzalone has extensive experience in biotechnology, nanotechnology, company-building and venture capital. |
| 2017-02-01 | Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University. We believe Dr. Anzalone’s qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer; in addition, Dr. Anzalone has extensive experience in biotechnology, nanotechnology, company-building and venture capital. |
Data sourced from SEC filings. Last updated: 2025-08-30